Eman A. Mazyed

463 total citations
18 papers, 362 citations indexed

About

Eman A. Mazyed is a scholar working on Pharmaceutical Science, Molecular Biology and Dermatology. According to data from OpenAlex, Eman A. Mazyed has authored 18 papers receiving a total of 362 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pharmaceutical Science, 3 papers in Molecular Biology and 3 papers in Dermatology. Recurrent topics in Eman A. Mazyed's work include Advancements in Transdermal Drug Delivery (10 papers), Advanced Drug Delivery Systems (8 papers) and Drug Solubulity and Delivery Systems (7 papers). Eman A. Mazyed is often cited by papers focused on Advancements in Transdermal Drug Delivery (10 papers), Advanced Drug Delivery Systems (8 papers) and Drug Solubulity and Delivery Systems (7 papers). Eman A. Mazyed collaborates with scholars based in Egypt, Saudi Arabia and United States. Eman A. Mazyed's co-authors include Farid A. Badria, Doaa A. Helal, Amira H. Hassan, Abdullah A. Elgazar, Nemany A. N. Hanafy, Engy Elekhnawy, Matti Haukka, Assem Barakat, Galal Magdy and Fardous F. El‐Senduny and has published in prestigious journals such as Scientific Reports, Molecules and International Journal of Nanomedicine.

In The Last Decade

Eman A. Mazyed

16 papers receiving 357 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eman A. Mazyed Egypt 10 190 72 59 47 45 18 362
Doaa A. Helal Egypt 11 200 1.1× 69 1.0× 57 1.0× 42 0.9× 43 1.0× 21 366
Walaa A. Abualsunun Saudi Arabia 14 145 0.8× 72 1.0× 43 0.7× 60 1.3× 39 0.9× 26 396
Viliana Gugleva Bulgaria 11 196 1.0× 90 1.3× 57 1.0× 48 1.0× 62 1.4× 22 384
Aristote B. Buya Democratic Republic of the Congo 7 224 1.2× 87 1.2× 61 1.0× 42 0.9× 28 0.6× 9 446
Mona M. AbouSamra Egypt 13 193 1.0× 74 1.0× 73 1.2× 58 1.2× 30 0.7× 22 402
Alshaimaa M. Almehmady Saudi Arabia 14 197 1.0× 92 1.3× 55 0.9× 79 1.7× 37 0.8× 25 459
Mohammed Aslam India 10 256 1.3× 134 1.9× 58 1.0× 49 1.0× 53 1.2× 21 445
Gehan F. Balata Egypt 13 316 1.7× 105 1.5× 88 1.5× 67 1.4× 32 0.7× 30 527
Shaimaa Mosallam Egypt 11 200 1.1× 81 1.1× 53 0.9× 52 1.1× 31 0.7× 21 369
Emre Şefik Çağlar Türkiye 11 193 1.0× 47 0.7× 47 0.8× 44 0.9× 55 1.2× 34 342

Countries citing papers authored by Eman A. Mazyed

Since Specialization
Citations

This map shows the geographic impact of Eman A. Mazyed's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eman A. Mazyed with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eman A. Mazyed more than expected).

Fields of papers citing papers by Eman A. Mazyed

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eman A. Mazyed. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eman A. Mazyed. The network helps show where Eman A. Mazyed may publish in the future.

Co-authorship network of co-authors of Eman A. Mazyed

This figure shows the co-authorship network connecting the top 25 collaborators of Eman A. Mazyed. A scholar is included among the top collaborators of Eman A. Mazyed based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eman A. Mazyed. Eman A. Mazyed is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Barakat, Assem, Fardous F. El‐Senduny, Mohammad Shahidul Islam, et al.. (2025). Nanoformulation of Spirooxindole and Methods for Treating Hepatocellular Carcinoma. Pharmaceutics. 17(1). 93–93.
2.
Mazyed, Eman A., et al.. (2025). Niosomes for enhanced oral delivery of pioglitazone: in vitro characterization and in vivo evaluation. Journal of Pharmacy and Pharmacology. 77(8). 1075–1084.
3.
Mazyed, Eman A., et al.. (2024). Formulation and characterization of quercetin-loaded Prunus armeniaca gum nanoparticles with enhanced anti-bacterial effect. Journal of Drug Delivery Science and Technology. 94. 105485–105485. 10 indexed citations
4.
Mazyed, Eman A., et al.. (2024). Glyceroniosomes for enhanced intestinal absorption of hydrochlorothiazide and lisinopril in their fixed dose combination. Scientific Reports. 14(1). 24499–24499. 1 indexed citations
5.
Mazyed, Eman A., et al.. (2024). Preparation of orodispersible tablets of bosentan using xylitol and menthol as dissolution enhancers. Scientific Reports. 14(1). 10680–10680. 1 indexed citations
6.
Mazyed, Eman A., et al.. (2024). Bio-friendly oleic acid-based ufasomal topical gel of rosuvastatin for diabetic wound healing: In-vitro, ex-Vivo, and in-Vivo evaluation. Journal of Drug Delivery Science and Technology. 97. 105789–105789. 6 indexed citations
7.
Maghraby, Gamal M. El, et al.. (2023). Co-processing of fluconazole with menthol for enhanced dissolution and anti-fungal activity: Preparation of orodispersable tablets. Journal of Drug Delivery Science and Technology. 88. 104937–104937. 3 indexed citations
8.
9.
Mostafa, Nada M., et al.. (2023). Formulation of Deformable Liponiosomal Hybrid of Repaglinide: In vitro Characterization and Evaluation of the Anti-Diabetic Effect. International Journal of Nanomedicine. Volume 18. 7417–7440. 2 indexed citations
10.
Barakat, Assem, Abdullah Mohammed Al‐Majid, Matti Haukka, et al.. (2022). Novel spirooxindole based benzimidazole scaffold: In vitro, nanoformulation and in vivo studies on anticancer and antimetastatic activity of breast adenocarcinoma. Bioorganic Chemistry. 129. 106124–106124. 17 indexed citations
11.
Mazyed, Eman A., et al.. (2022). Patient-friendly extemporaneous formulation of bisoprolol: application to stability and bioavailability studies. Drug Delivery and Translational Research. 13(3). 795–810. 3 indexed citations
12.
13.
Mazyed, Eman A., et al.. (2021). Formulation and Optimization of Nanospanlastics for Improving the Bioavailability of Green Tea Epigallocatechin Gallate. Pharmaceuticals. 14(1). 68–68. 64 indexed citations
14.
15.
Badria, Farid A., et al.. (2020). Formulation of Sodium Valproate Nanospanlastics as a Promising Approach for Drug Repurposing in the Treatment of Androgenic Alopecia. Pharmaceutics. 12(9). 866–866. 37 indexed citations
16.
17.
18.
Mazyed, Eman A., et al.. (2019). ENHANCEMENT OF DISSOLUTION CHARACTERISTICS OF CLOPIDOGREL BISULPHATE BY PRONIOSOMES. International Journal of Applied Pharmaceutics. 77–85. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Doaa A. Helal Breakdown of academic impact, for papers by Walaa A. Abualsunun Breakdown of academic impact, for papers by Viliana Gugleva Breakdown of academic impact, for papers by Aristote B. Buya Breakdown of academic impact, for papers by Mona M. AbouSamra Breakdown of academic impact, for papers by Alshaimaa M. Almehmady Breakdown of academic impact, for papers by Mohammed Aslam Breakdown of academic impact, for papers by Gehan F. Balata Breakdown of academic impact, for papers by Shaimaa Mosallam Breakdown of academic impact, for papers by Emre Şefik Çağlar
Rankless by CCL
2026